MedPath

Efficacy Of Ayurvedic NEEM AYU Anti Hairfall Kit On Reducing Hair Loss

Phase 4
Completed
Conditions
Health Condition 1: L659- Nonscarring hair loss, unspecified
Registration Number
CTRI/2022/01/039741
Lead Sponsor
Med Pharma CRO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Male and female subjectsââ?¬• in general good health.

2.Subjects in the age group 18-65 years (both the ages inclusive).

3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.

4.Subjects willing to abide by and comply with the study protocol.

5.Subjects who have not participated in a similar investigation in the past three months.

6.Subjects complaining of hair fall and damage.

7.Healthy volunteers with no known allergy as established by medical history.

8.Subjects who do not smoke or drink

9.Subjects who are not crash dieting.

10.Subjects who agree to refrain from using hair dye / hair colour during the study period.

11.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration.

12.Subjects who are willing to refrain from any other oil treatment/hair spa and oral medications for hair growth during the study.

Exclusion Criteria

1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.

2.Subjects having any active scalp disease such as scalp Psoriasis which may interfere in the study- dermatologistââ?¬•s judgments.

3.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.

4.Subjects who have history of alcoholism and/ or psychiatric disorder.

5.Subjects who have had hair transplant.

6.Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia.

7.Subjects with a known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.

8.Subjects consuming alcohol and smoking.

9.Subjects on oral medications such as vitamin supplements, including multi-vitamins which will compromise the study.

10.Subjects who are pregnant or lactating or nursing as established with medical history

11.Subjects under medical treatment for hair problems, prescription drugs such as Minoxidil, Finasteride, or any 5 �±-reductase inhibitor or light therapy.

12.Subjects undergoing any chemical hair salon treatment-straightening / perming / colour

13.Subjects with chronic illness which may influence the cutaneous state.

14.Subjects participating in other similar cosmetic or therapeutic trial within last three months.

15.Subjects with medical history of thyroid disorders.

16.Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

17.Subjects who have experienced a known stressful event within the last 6 months such as death in family, miscarriage etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath